阿立哌唑合并抗抑郁药治疗抑郁症的临床疗效及安全性研究

Study on the clinical effect and safety of aripiprazole combined with antidepressants in the treatment of depression

目的探讨阿立哌唑合并抗抑郁药(三环类抗抑郁剂阿米替林)治疗抑郁症的临床疗效及安全性。方法选择120例抑郁症患者随机分为研究组和对照组。对照组给予常规抗抑郁药物治疗,研究组在常规抗抑郁治疗基础上给予阿立哌唑。采用汉密尔顿抑郁量表和副反应量表对两组患者治疗前和治疗后进行评定。结果研究组治疗后的第1、2、4、6周汉密尔顿抑郁量表评分分别与对照组同期比较,差异有统计学意义(P<0.05)。研究组治疗后的总有效率高于对照组,差异有统计学意义(P<0.05)。研究组副反应量表评分和对照组比较,差异无统计学意义(P>0.05)。结论阿立哌唑能够提高抗抑郁药(三环类抗抑郁剂阿米替林)治疗抑郁症的临床治疗效果,可作为临床抗抑郁治疗的一种增效手段。

Objective To study clinical effect and safety of aripiprazole combined with antidepressants（tricyclic antidepressants amitriptyline） in the treatment of depression. Methods From January 2010 to December 2013, 120 patients with depression patients were selected and randomly divided into study group and control group, control group was given regular treatment of antidepressant drugs, study group was given aripiprazole combined with antidepressants（tricyclic antidepressants amitriptyline）. The Hamilton Depression Scale（HAMD） and Treatment Emergent Symptom Scale（TESS） were used in the two group s of patients before and after treatment. Results Hamilton Depression Scale scores in the study group after treatment of the first week, second week, fourth week and sixth week of study group was compared with those in control group, the difference was statistically significant（P〈0.05）. The total efficacy rate in study group was higher than that in control group, the difference was statistically significant（P〈0.05）; there was no statistically significant of the side effects scale score in observation group compared with control group（P〉0.05）. Conclusion Aripiprazole can improve the clinical efficacy of antidepressants（tricyclic antidepressants amitriptyline） in the treatment of depression, which can be one of the augmentations in the treatment of depression.